News &Â Press.
Learn the Latest Aziyo Updates
Aziyo Biologics to Report Second Quarter 2022 Financial Results on August 11, 2022
SILVER SPRING, Md., July 28, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients...
Aziyo Biologics Appoints Dr. C. Randal Mills as Interim President and CEO
SILVER SPRING, Md., June 21, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients...
Aziyo Biologics Provides Business Update and Reports First Quarter 2022 Financial Results
SILVER SPRING, Md., May 09, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients...
Aziyo Biologics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
SILVER SPRING, Md., April 25, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients...
Aziyo Biologics Announces Upcoming KOL Call Hosted by Cowen – Call to Highlight the Use and Benefits of Aziyo’s CanGaroo Envelope for Implantable Electronic Devices
SILVER SPRING, Md., April 12, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients...